Works matching AU Sherman, Matthew L.


Results: 19
    1

    A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.

    Published in:
    2019
    By:
    • Voss, Martin H.;
    • Bhatt, Rupal S.;
    • Vogelzang, Nicholas J.;
    • Fishman, Mayer;
    • Alter, Robert S.;
    • Rini, Brian I.;
    • Beck, J. Thaddeus;
    • Joshi, Monika;
    • Hauke, Ralph;
    • Atkins, Michael B.;
    • Burgess, Earle;
    • Logan, Theodore F.;
    • Shaffer, David;
    • Parikh, Rahul;
    • Moazzam, Nauman;
    • Zhang, Xiaosha;
    • Glasser, Chad;
    • Sherman, Matthew L.;
    • Plimack, Elizabeth R.
    Publication type:
    journal article
    2
    3
    4

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

    Published in:
    2005
    By:
    • Larson, Richard A;
    • Sievers, Eric L;
    • Stadtmauer, Edward A;
    • Löwenberg, Bob;
    • Estey, Elihu H;
    • Dombret, Hervé;
    • Theobald, Matthias;
    • Voliotis, Dimitris;
    • Bennett, John M;
    • Richie, Maria;
    • Leopold, Lance H;
    • Berger, Mark S;
    • Sherman, Matthew L;
    • Loken, Michael R;
    • van Dongen, Jacques J M;
    • Bernstein, Irwin D;
    • Appelbaum, Frederick R
    Publication type:
    journal article
    5

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326
    By:
    • Richard A. Larson;
    • Eric L. Sievers;
    • Edward A. Stadtmauer;
    • Bob Löwenberg;
    • Elihu H. Estey;
    • Hervé Dombret;
    • Matthias Theobald;
    • Dimitris Voliotis;
    • John M. Bennett;
    • Maria Richie;
    • Lance H. Leopold;
    • Mark S. Berger;
    • Matthew L. Sherman;
    • Michael R. Loken;
    • Jacques J. M. van Dongen;
    • Irwin D. Bernstein;
    • Frederick R. Appelbaum
    Publication type:
    Article
    6
    7
    8

    Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.

    Published in:
    Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917
    By:
    • Zalcberg, John R.;
    • Heinrich, Michael C.;
    • George, Suzanne;
    • Bauer, Sebastian;
    • Schöffski, Patrick;
    • Serrano, César;
    • Gelderblom, Hans;
    • Jones, Robin L.;
    • Attia, Steven;
    • D'Amato, Gina;
    • Chi, Ping;
    • Reichardt, Peter;
    • Somaiah, Neeta;
    • Meade, Julie;
    • Reichert, Vienna;
    • Shi, Kelvin;
    • Sherman, Matthew L.;
    • Ruiz‐Soto, Rodrigo;
    • von Mehren, Margaret;
    • Blay, Jean‐Yves
    Publication type:
    Article
    9
    10
    11
    12
    13

    Sotatercept in patients with osteolytic lesions of multiple myeloma.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 6, p. 814, doi. 10.1111/bjh.12835
    By:
    • Abdulkadyrov, Kudrat M.;
    • Salogub, Galina N.;
    • Khuazheva, Nuriet K.;
    • Sherman, Matthew L.;
    • Laadem, Abderrahmane;
    • Barger, Rachel;
    • Knight, Robert;
    • Srinivasan, Shankar;
    • Terpos, Evangelos
    Publication type:
    Article
    14

    The Role for Interleukin-12 Therapy of Cutaneous T Cell Lymphoma.

    Published in:
    Annals of the New York Academy of Sciences, 2001, v. 941, n. 1, p. 177, doi. 10.1111/j.1749-6632.2001.tb03721.x
    By:
    • ROOK, ALAIN H.;
    • ZAKI, MOHAMED H.;
    • WYSOCKA, MARIA;
    • WOOD, GARY S.;
    • DUVIC, MADELEINE;
    • SHOWE, LOUISE C.;
    • FOSS, FRANCINE;
    • SHAPIRO, MICHAEL;
    • KUZEL, TIMOTHY M.;
    • OLSEN, ELISE A.;
    • VONDERHEID, ERIC C.;
    • LALIBERTE, ROBERT;
    • SHERMAN, MATTHEW L.
    Publication type:
    Article
    15

    Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.

    Published in:
    2016
    By:
    • Raftopoulos, Haralambos;
    • Glaspy, John;
    • Crawford, Jeffrey;
    • Laadem, Abderrahmane;
    • Puccio-Pick, Marie;
    • Zou, Jun;
    • Hesketh, Paul;
    • Goldschmidt, Jerome;
    • Gabrail, Nashat;
    • Osborne, Cynthia;
    • Ali, Muhammad;
    • Sherman, Matthew;
    • Wang, Ding;
    • Hesketh, Paul J;
    • Sherman, Matthew L;
    • Glaspy, John A
    Publication type:
    journal article
    16
    17
    18
    19